Community-acquired methicillin-resistant Staphylococcus aureus mycotic aneurysm.
暂无分享,去创建一个
W. Ko | N. Lee | Po-Lin Chen | Hsin-Chun Lee | Chi-Jung Wu | C. Kan | Chia-Yu Chi | Chia‐Ming Chang | Chi‐Jung Wu
[1] P. Wayne. CLINICAL AND LABORATORY STANDARDS INSTITUTE. PERFORMANCE STANDARDS FOR ANTIMICROBIAL SUSCEPTIBILITY TESTING , 2011 .
[2] H. Boucher,et al. Epidemiology of methicillin-resistant Staphylococcus aureus. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[3] R. Wenzel,et al. Antibiotic options for treating community-acquired MRSA , 2008, Expert review of anti-infective therapy.
[4] J. Schefold,et al. Therapy-refractory Panton Valentine Leukocidin-positive community-acquired methicillin-sensitive Staphylococcus aureus sepsis with progressive metastatic soft tissue infection: a case report , 2007, Journal of medical case reports.
[5] S. Micek. Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[6] R. Daum. Skin and Soft-Tissue Infections Caused by Methicillin-Resistant Staphylococcus aureus , 2007 .
[7] F. Vandenesch,et al. Effect of Antibiotics on Staphylococcus aureus Producing Panton-Valentine Leukocidin , 2007, Antimicrobial Agents and Chemotherapy.
[8] R. Daum,et al. Clinical practice. Skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus. , 2007, The New England journal of medicine.
[9] T. Bower. Surgical treatment of infected aneurysms and pseudoaneurysms of the thoracic and abdominal aorta. , 2006, Perspectives in vascular surgery and endovascular therapy.
[10] M. Pai,et al. Epidemiology of Vancomycin-Induced Neutropenia In Patients Receiving Home Intravenous Infusion Therapy , 2006, The Annals of pharmacotherapy.
[11] H. Maltezou,et al. Community-acquired methicillin-resistant Staphylococcus aureus infections. , 2006, International journal of antimicrobial agents.
[12] James S. Lewis,et al. Treatment approaches for community-acquired methicillin-resistant Staphylococcus aureus infections , 2005, Current opinion in infectious diseases.
[13] Yhu-Chering Huang,et al. Community-acquired methicillin-resistant Staphylococcus aureus in Taiwan. , 2005, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.
[14] D. Osmon,et al. Epidemiology, treatment, and prevention of community-acquired methicillin-resistant Staphylococcus aureus infections. , 2005, Mayo Clinic proceedings.
[15] William R Bishai,et al. Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat. , 2005, The Lancet. Infectious diseases.
[16] V. Yu,et al. Similar hematologic effects of long-term linezolid and vancomycin therapy in a prospective observational study of patients with orthopedic infections. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[17] R. J. Valentine,et al. Surgical mortality in patients with infected aortic aneurysms. , 2003, Journal of the American College of Surgeons.
[18] L. John,et al. Linezolid versus Vancomycin for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections , 2002 .
[19] C. Clase,et al. Ruptured mycotic thoracoabdominal aortic aneurysms: a report of three cases and a systematic review. , 2001, Journal of vascular surgery.
[20] H. Chambers,et al. The changing epidemiology of Staphylococcus aureus? , 2001, Emerging infectious diseases.
[21] M. Ferraro. Performance standards for antimicrobial susceptibility testing , 2001 .